Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

June 1, 2022; Volume 63,Issue Supplement 1
  • You have access
    Molecular Imaging of Neurodegeneration: The Way to New Horizons
    Victor L. Villemagne and Henryk Barthel
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 1S; DOI: https://doi.org/10.2967/jnumed.121.264237
  • You have access
    18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies
    Satoshi Minoshima, Donna Cross, Tanyaluck Thientunyakit, Norman L. Foster and Alexander Drzezga
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 2S-12S; DOI: https://doi.org/10.2967/jnumed.121.263194
  • The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
    You have access
    The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
    Marianne Chapleau, Leonardo Iaccarino, David Soleimani-Meigooni and Gil D. Rabinovici
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 13S-19S; DOI: https://doi.org/10.2967/jnumed.121.263195
  • You have access
    Tau PET Imaging in Neurodegenerative Disorders
    Colin Groot, Sylvia Villeneuve, Ruben Smith, Oskar Hansson and Rik Ossenkoppele
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 20S-26S; DOI: https://doi.org/10.2967/jnumed.121.263196
  • Open Access
    Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders
    Elon D. Wallert, Elsmarieke van de Giessen, Remco J.J. Knol, Martijn Beudel, Rob M.A. de Bie and Jan Booij
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 27S-32S; DOI: https://doi.org/10.2967/jnumed.121.263197
  • You have access
    PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
    Solveig Tiepolt, Philipp M. Meyer, Marianne Patt, Winnie Deuther-Conrad, Swen Hesse, Henryk Barthel and Osama Sabri
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 33S-44S; DOI: https://doi.org/10.2967/jnumed.121.263198
  • You have access
    Imaging Neuroinflammation in Neurodegenerative Disorders
    Joseph C. Masdeu, Belen Pascual and Masahiro Fujita
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 45S-52S; DOI: https://doi.org/10.2967/jnumed.121.263200
  • You have access
    Cyclooxygenases as Potential PET Imaging Biomarkers to Explore Neuroinflammation in Dementia
    Bruny V. Kenou, Lester S. Manly, Sara B. Rubovits, Somachukwu A. Umeozulu, Maia G. Van Buskirk, Andrea S. Zhang, Victor W. Pike, Paolo Zanotti-Fregonara, Ioline D. Henter and Robert B. Innis
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 53S-59S; DOI: https://doi.org/10.2967/jnumed.121.263199
  • You have access
    Imaging of Synaptic Density in Neurodegenerative Disorders
    Richard E. Carson, Mika Naganawa, Takuya Toyonaga, Sheida Koohsari, Yanghong Yang, Ming-Kai Chen, David Matuskey and Sjoerd J. Finnema
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 60S-67S; DOI: https://doi.org/10.2967/jnumed.121.263201
  • You have access
    Future Directions in Molecular Imaging of Neurodegenerative Disorders
    Henryk Barthel, Victor L. Villemagne and Alexander Drzezga
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 68S-74S; DOI: https://doi.org/10.2967/jnumed.121.263202
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (Supplement 1)
Journal of Nuclear Medicine
Vol. 63, Issue Supplement 1
June 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Molecular Imaging of Neurodegeneration: The Way to New Horizons
  • Future Directions in Molecular Imaging of Neurodegenerative Disorders
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire